Botanix Pharmaceuticals Limited (AU:BOT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Botanix Pharmaceuticals Ltd has announced the issuance of 36 million performance rights under an employee incentive scheme, which are not intended for public trading on the ASX. This move could signify strategic efforts to motivate and retain key employees as the company advances its business objectives.
For further insights into AU:BOT stock, check out TipRanks’ Stock Analysis page.